Edesa Biotech Inc Sustainability Reports
A clinical-stage biopharmaceutical company focused on acquiring, developing, and commercializing innovative drugs for inflammatory and immune-related diseases.
Sector: Manufacturing
Country: Canada
Exchange: Nasdaq
FIGI: BBG001SPM284
2 reports from 2023 to 2024
Company Profile
A clinical-stage biopharmaceutical company focused on acquiring, developing, and commercializing innovative drugs for inflammatory and immune-related diseases.
Reports
2 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
